trd205
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 26, 2024 (NCT07123428)
Timeline
Indications
Studied for
Mechanism of action
- Type-1 angiotensin II receptorANTAGONIST
AGTR1 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07121101 | Phase 2 | Sep 26, 2025 | Beijing Tide Pharmaceutical Co., Ltd, Southern Medical University |
| NCT07121023 | Phase 1 | Aug 26, 2025 | Beijing Tide Pharmaceutical Co., Ltd, Peking University |
| NCT07123402 | Phase 2 | Apr 9, 2025 | Beijing Tide Pharmaceutical Co., Ltd, Peking University |
| NCT07123428 | Phase 1 | Jan 26, 2024 | Beijing Tide Pharmaceutical Co., Ltd |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Beijing Tide Pharmaceutical Co., Ltd | For profit | 4 | 4 | 2 | 2024 |
| Peking University | Academic/Hospital | 2 | 0 | 2 | 2025 |
| Southern Medical University | Academic/Hospital | 1 | 0 | 1 | 2025 |
3 organizations
Page 1 / 1